954 filings
Page 7 of 48
4
Mann Paul Elliot
28 Sep 22
ABEONA THERAPEUTICS / Paul Elliot Mann ownership change
4:34pm
4
Mark Alvino
28 Sep 22
ABEONA THERAPEUTICS / Mark Alvino ownership change
4:33pm
4
Donald A. Wuchterl
28 Sep 22
ABEONA THERAPEUTICS / Donald A. Wuchterl ownership change
4:32pm
4
Brendan M. O'Malley
22 Sep 22
ABEONA THERAPEUTICS / Brendan M. O'Malley ownership change
4:36pm
S-8
ABEO
Abeona Therapeutics Inc
31 Aug 22
Registration of securities for employees
4:21pm
8-K
ABEO
Abeona Therapeutics Inc
17 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
10-Q
2022 Q2
ABEO
Abeona Therapeutics Inc
Quarterly report
11 Aug 22
7:40am
8-K
ABEO
Abeona Therapeutics Inc
11 Aug 22
Abeona Therapeutics Reports Second Quarter 2022 Financial Results
7:30am
DEFA14A
ABEO
Abeona Therapeutics Inc
4 Aug 22
Additional proxy soliciting materials
5:00pm
4
Vazzano Joseph Walter
25 Jul 22
ABEONA THERAPEUTICS / Joseph Walter Vazzano ownership change
6:17pm
8-K
ABEO
Abeona Therapeutics Inc
20 Jul 22
Other Events
7:30am
424B5
ABEO
Abeona Therapeutics Inc
19 Jul 22
Prospectus supplement for primary offering
5:15pm
DEF 14A
ABEO
Abeona Therapeutics Inc
Definitive proxy
11 Jul 22
5:16pm
8-K
ABEO
Abeona Therapeutics Inc
30 Jun 22
Material Modifications to Rights of Security Holders
5:00pm
4
Mark Alvino
17 Jun 22
ABEONA THERAPEUTICS / Mark Alvino ownership change
4:17pm
4
ABEO
Abeona Therapeutics Inc
17 Jun 22
ABEONA THERAPEUTICS / Vishwas Seshadri ownership change
4:13pm
8-K
ABEO
Abeona Therapeutics Inc
14 Jun 22
Submission of Matters to a Vote of Security Holders
5:05pm
4
Mark Alvino
7 Jun 22
ABEONA THERAPEUTICS / Mark Alvino ownership change
4:05pm
8-K
ABEO
Abeona Therapeutics Inc
19 May 22
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
7:35am
8-K
ABEO
Abeona Therapeutics Inc
17 May 22
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics
8:01am